Selected by the National Cancer Institute's PREVENT Cancer Preclinical Drug Development Program for breast cancer.
Founder has taken 10 approved drugs to the FDA & EMA and failed only once.
Received $3.7MM grant from EU supported fund in Poland for Triple Negative Breast Cancer Treatment.
GLG Pharma's Hector J Gomez, MD, PhD, CEO & Cofounder and Richard Gabriel, COO & Cofounder will be at the Dawson James conference for companies on Oc...
Here is a link to a new video interview with Richard Gabriel, COO & Co-founder about the technology and other information!
Already have an account? Login
Don't have an account? Signup